ECM
BIIB icon

Exchange Capital Management’s Biogen BIIB Stock Holding History

Exchange Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,139
Closed -$4.67M – 195
2024
Q2 		$4.67M Sell
20,139
-209
-1% -$45.4K 0.76% 40
2024
Q1 		$4.39M Buy
20,348
+50
+0.2% +$11.7K 0.71% 44
2023
Q4 		$5.25M Buy
20,298
+920
+5% +$226K 0.94% 33
2023
Q3 		$4.98M Sell
19,378
-190
-1% -$50.8K 0.94% 34
2023
Q2 		$5.57M Sell
19,568
-124
-0.6% -$36.9K 1.04% 29
2023
Q1 		$5.47M Buy
19,692
+297
+2% +$82.2K 1.11% 28
2022
Q4 		$5.37M Sell
19,395
-802
-4% -$227K 1.18% 24
2022
Q3 		$5.39M Sell
20,197
-280
-1% -$59.5K 1.25% 20
2022
Q2 		$4.18M Buy
20,477
+126
+0.6% +$25.8K 0.91% 39
2022
Q1 		$4.29M Buy
20,351
+855
+4% +$186K 0.8% 43
2021
Q4 		$4.68M Buy
19,496
+643
+3% +$165K 0.85% 42
2021
Q3 		$5.33M Sell
18,853
-675
-3% -$221K 1.03% 31
2021
Q2 		$6.76M Buy
19,528
+464
+2% +$141K 1.3% 23
2021
Q1 		$5.33M Buy
19,064
+791
+4% +$213K 1.1% 32
2020
Q4 		$4.47M Buy
18,273
+5,375
+42% +$1.39M 1% 37
2020
Q3 		$3.66M Buy
12,898
+432
+3% +$120K 0.93% 39
2020
Q2 		$3.33M Sell
12,466
-133
-1% -$40K 0.92% 40
2020
Q1 		$3.99M Buy
12,599
+1,589
+14% +$482K 1.3% 26
2019
Q4 		$3.27M Buy
11,010
+3,019
+38% +$838K 0.84% 45
2019
Q3 		$1.86M Buy
+7,991
New +$1.86M 0.49% 69
2015
Q1 		– Sell
-4
Closed -$1K – 106
2014
Q4 		$1K Buy
+4
New +$1.29K ﹤0.01% 320

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exchange Capital Management's BIIB Position: Q3 2024 in Review

Exchange Capital Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 20,139 shares — an estimated $4.67M sold.

Exchange Capital Management first reported a position in BIIB in Q4 2014 and held it in 21 quarters. The position peaked at $6.76M in Q2 2021. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Exchange Capital Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Exchange Capital Management sold 20,139 Biogen shares in Q3 2024, an estimated $4.67M.
  • Exchange Capital Management first reported a position in Biogen in Q4 2014 and held it in 21 quarters.
  • Exchange Capital Management's Biogen position peaked at $6.76M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Exchange Capital Management's 13F filing for Q3 2024, filed 1 Nov 2024.